Saturday, May 26, 2007 2:54:25 PM
JAV - Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc., together with its subsidiaries, engages in the research, development, and commercialization of products for pain relief in the United States. Its product candidates include Dyloject, which is in Phase III development stage for the treatment of post-operative pain in the United States, as well as in MAA Review stage for the treatment of acute forms of pain, including renal colic, exacerbations of osteo and rheumatoid arthritis, acute back pain, acute gout, acute trauma, and pain associated with fractures in Europe.
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
.
.
Javelin Pharmaceuticals, Inc., together with its subsidiaries, engages in the research, development, and commercialization of products for pain relief in the United States. Its product candidates include Dyloject, which is in Phase III development stage for the treatment of post-operative pain in the United States, as well as in MAA Review stage for the treatment of acute forms of pain, including renal colic, exacerbations of osteo and rheumatoid arthritis, acute back pain, acute gout, acute trauma, and pain associated with fractures in Europe.
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
